- OVERVIEW
- PRODUCTS
- Casting & Splinting
- Hand Hygiene
- Patient Monitoring
- Securement and Immobilization
- Skin Care
- Wound Care
- Sterilization & Monitoring
- Surgical Solutions
- Vascular Access
- View all
- CONDITIONS
- Bloodstream Infections
- Incision Management
- Surgical Site Infections
- Incontinence-Associated Dermatitis
- Pressure Injury Prevention
- Wound Care
- EDUCATION
- SUPPORT
Thank You
Your form was submitted successfully!
Our Apologies...
An error has occurred while submitting. Please try again later...
Bringing your best. Every patient. Every time.
You’re here for your patients. We’re here for you.
-
As surgeries resume, we understand you’re balancing so many priorities including patient and staff respiratory protection, inventory and staffing challenges, and managing patient flow – all with new restrictions.
Treating every patient with the highest level of care is more important now than ever. Addressing risk by implementing standardised practices around evidence-based protocols for every patient will help reduce the risk of surgical site infection and other complications. Complications that can reduce your efficiency and may impact other factors such as access, quality, and cost of patient care. 3M is here to help with science-centered solutions and clinically efficacious therapies, so you can focus on what matters most.
3M™ Skin & Nasal Antiseptic effectively reduces nasal carriage of broad-spectrum organisms - including S. Aureus - to help reduce the risk of surgical site infection (SSI) when part of a comprehensive preoperative protocol.
Learn More3M™ Skin & Nasal Antiseptic effectively reduces nasal carriage of broad-spectrum organisms - including S. Aureus - to help reduce the risk of surgical site infection (SSI) when part of a comprehensive preoperative protocol.
Learn MoreAs the #1 surgical hand antiseptic in the U.S., Avagard CHG kills a broad spectrum of microbes including antibiotic-resistant strains, and is proven to provide a greater than 99% microbial kill in 15 seconds.3,4
As the #1 surgical hand antiseptic in the U.S., Avagard CHG kills a broad spectrum of microbes including antibiotic-resistant strains, and is proven to provide a greater than 99% microbial kill in 15 seconds.3,4
3M™ DuraPrep™ Surgical Patient Preoperative Skin Preparation provides both rapid bacterial kill and long lasting antimicrobial persistence that resists wash-off and maintains persistence for up to 48 hours.6
3M™ DuraPrep™ Surgical Patient Preoperative Skin Preparation provides both rapid bacterial kill and long lasting antimicrobial persistence that resists wash-off and maintains persistence for up to 48 hours.6
CRBSIs can lead to 12-24 more days of hospitalization and CLABSIs cost an average of $45,000 per patient.7,8
CRBSIs can lead to 12-24 more days of hospitalization and CLABSIs cost an average of $45,000 per patient.7,8
3M™ Ioban™ 2 Antimicrobial Incise Drape provides continuous broad-spectrum antimicrobial activity to help reduce the risk of surgical site contamination that may be associated with surgical site infection.
Learn More3M™ Ioban™ 2 Antimicrobial Incise Drape provides continuous broad-spectrum antimicrobial activity to help reduce the risk of surgical site contamination that may be associated with surgical site infection.
Learn MoreThe right respiratory protection is important to protect yourself and your patients.
Learn MoreThe right respiratory protection is important to protect yourself and your patients.
Learn MoreEconomic models show that V.A.C. VERAFLO™ Therapy, compared to V.A.C.® Therapy, may help reduce the total cost of care for patients with infected or contaminated wounds through reduced length of hospital stay, trips to the OR, and length of therapy.9
Economic models show that V.A.C. VERAFLO™ Therapy, compared to V.A.C.® Therapy, may help reduce the total cost of care for patients with infected or contaminated wounds through reduced length of hospital stay, trips to the OR, and length of therapy.9
PREVENA™ Therapy aids in reducing the incidence of seroma and superficial surgical site infections in Class I and Class II wounds.
Learn MorePREVENA™ Therapy aids in reducing the incidence of seroma and superficial surgical site infections in Class I and Class II wounds.
Learn MoreEven a minor drop in core body temperature can result in unintended hypothermia, a common, yet preventable complication associated with an increased risk of SSI, longer length of hospital stay, and other costly, potentially deadly consequences.5,10
Even a minor drop in core body temperature can result in unintended hypothermia, a common, yet preventable complication associated with an increased risk of SSI, longer length of hospital stay, and other costly, potentially deadly consequences.5,10
You cannot efficiently manage what you do not accurately measure.5 Get consistent, accurate, continuous, connected, non-invasive core temperature monitoring from a sensor on the skin’s surface.
You cannot efficiently manage what you do not accurately measure.5 Get consistent, accurate, continuous, connected, non-invasive core temperature monitoring from a sensor on the skin’s surface.
References
-
1.Phillips M., et al. Preventing Surgical Site Infections: A Randomized, Open-Label Trial of Nasal Mupirocin Ointment and Nasal Povidone-Iodine Solution. Infect Control Hosp Epidemiol 2014;35(7):826-32
2.Bebko S., et al. Effect of a Preoperative Decontamination Protocol on Surgical Site Infections in Patients Undergoing Elective Orthopedic Surgery with Hardware Implantation. JAMA Surg, Published online March 04, 2015. doi:10.1001/jamasurg.2014.3480
3.Per HPIS Data as of 03/2011.
4.Data on file (LIMS 8257), 3M Health Care. AORN is a registered trademark of AORN, Inc. AORN does not endorse any commercial company’s products or services."
5.Sessler DI. Mild Perioperative Hypothermia. N Engl J Med 1997; 336:1730-1737.
6.Stahl JB, Morse D, Parks PJ. Resistance of antimicrobial skin preparations to saline rinse using a seeded bacteria model. Am J Infect Control. 2007;35:367-73.
7.Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046.
8.Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41(11):1591-8.
9.Gabriel A, et al, Use of negative pressure wound therapy with automated, volumetric instillation for the treatment of extremity and trunk wounds: clinical outcomes and potential cost-effectiveness, Eplasty, 2014; 14:341.
10.Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. The Lancet. 2001 Sep 15;358(9285):876-80.
-
Protecting YouRespiratory protection information to help keep you safe in the fight against COVID-19
Respiratory Protection for Surgical Settings Guide (PDF, 680 KB)
-
Preparing ThemResources for patients
Download the surgical preparation guide to provide your patients (PDF, 1.4 MB)
-
Protect Incisions from Unwanted Surprises with PREVENA™ TherapyLearn more
-
The importance of patient warming
Read the latest response from 3M related to the ongoing importance of warming surgical patients even during the COVID-19 pandemic.
-
Continuing Education
Through the 3M℠ Health Care Academy, you can register for free webinars covering topics relevant to your clinical practice. Register for upcoming webinars, and access archives from recently conducted events.
References
-
1.Phillips M., et al. Preventing Surgical Site Infections: A Randomized, Open-Label Trial of Nasal Mupirocin Ointment and Nasal Povidone-Iodine Solution. Infect Control Hosp Epidemiol 2014;35(7):826-32
2.Bebko S., et al. Effect of a Preoperative Decontamination Protocol on Surgical Site Infections in Patients Undergoing Elective Orthopedic Surgery with Hardware Implantation. JAMA Surg, Published online March 04, 2015. doi:10.1001/jamasurg.2014.3480
3.Per HPIS Data as of 03/2011.
4.Data on file (LIMS 8257), 3M Health Care. AORN is a registered trademark of AORN, Inc. AORN does not endorse any commercial company’s products or services."
5.Sessler DI. Mild Perioperative Hypothermia. N Engl J Med 1997; 336:1730-1737.
6.Stahl JB, Morse D, Parks PJ. Resistance of antimicrobial skin preparations to saline rinse using a seeded bacteria model. Am J Infect Control. 2007;35:367-73.
7.Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046.
8.Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41(11):1591-8.
9.Gabriel A, et al, Use of negative pressure wound therapy with automated, volumetric instillation for the treatment of extremity and trunk wounds: clinical outcomes and potential cost-effectiveness, Eplasty, 2014; 14:341.
10.Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. The Lancet. 2001 Sep 15;358(9285):876-80.
